title: Autoregulation of phosphorylation of the nicotinic acetylcholine receptor.
abstract: We have investigated the regulation of phosphorylation of the nicotinic ACh receptor (nAChR) in rat myotubes by the agonist carbamylcholine. Treatment of primary rat myotube cultures with carbamylcholine resulted in a 100% increase in phosphorylation of the nAChR gamma- (52 kDa) subunit and a 30% increase in phosphorylation of the nAChR delta- (62 kDa) and delta'- (66 kDa) subunits. These responses to carbamylcholine were dose dependent, with a half-maximal response occurring at 10 microM and a maximum response achieved within 2 min. Pretreatment of myotubes with d-tubocurare, but not with atropine, inhibited carbamylcholine-stimulated phosphorylation of the nAChR. Preincubation with open-channel blockers of the nAChR also inhibited phosphorylation of the nAChR induced by carbamylcholine. Depletion of extracellular calcium from myotube cultures prevented carbamylcholine-stimulated increases in nAChR phosphorylation whereas application of a calcium ionophore mimicked the effect of carbamylcholine on nAChR phosphorylation. Pretreatment of myotubes with TTX did not inhibit carbamylcholine-stimulated nAChR phosphorylation and potassium depolarization of myotubes had no effect on nAChR phosphorylation. Carbamylcholine increased nAChR phosphorylation to the same extent and with the same time course and subunit specificity as that induced by phorbol esters. However, chronic treatment of myotubes with phorbol esters that eliminated any subsequent phorbol ester-stimulated nAChR phosphorylation did not diminish the increase in nAChR phosphorylation induced by carbamylcholine. The calmodulin antagonist W7 was similarly unable to inhibit carbamylcholine-stimulated nAChR phosphorylation. These results suggest that the nAChR is a substrate for an uncharacterized protein kinase in situ, and that activity of this protein kinase is stimulated by calcium ions that permeate through the activated nAChR ion channel.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Anatomy and Cell Biology, State University of New York Health Science Center at Brooklyn 11203.
authors.forename: K
authors.initials: K
authors.lastname: Miles
authors.forename: S S
authors.initials: SS
authors.lastname: Audigier
authors.forename: P
authors.initials: P
authors.lastname: Greengard
authors.forename: R L
authors.initials: RL
authors.lastname: Huganir
mesh_terms: D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002478:Cells, Cultured; D006706:Homeostasis; D015759:Ionomycin / Q000494:pharmacology; D009132:Muscles / Q000166:cytology / Q000187:drug effects / Q000196:embryology / Q000378:metabolism*; D018733:Nicotinic Antagonists; D010703:Phorbol Esters / Q000494:pharmacology; D010766:Phosphorylation / Q000187:drug effects; D051381:Rats; D011978:Receptors, Nicotinic / Q000378:metabolism*; D013779:Tetrodotoxin / Q000494:pharmacology
chemical_list: D002121:Calcium Channel Blockers; D018733:Nicotinic Antagonists; D010703:Phorbol Esters; D011978:Receptors, Nicotinic; D013779:Tetrodotoxin; D015759:Ionomycin; D002217:Carbachol